[ET Net News Agency, 30 September 2021] SIMCERE PHARMA (02096) fell 0.99% to HK$6.98.
It hits an intra-day low of HK$6.98, hitting a historical low, and an intra-day high of
HK$7.09. The total shares traded was 30,000, with a value of HK$211,590. The active
buy/sell ratio is 4:96, with net selling turnover of HK$183,230. BRIGHT SMART SEC INT'L
(HK) accounts for greatest net responsive buying turnover of HK$59,220, with volume
weighted average price of HK$7.05. HAITONG INT'L SEC accounts for greatest net responsive
selling turnover of HK$7,060, with volume weighted average price of HK$7.06. The stock has
fallen a combined 4.38% over the past 6 consecutive trading days.
The Hang Seng Index now fell 276 points, or 1.12% to 24,387; the Hang Seng China
Enterprises Index now fell 134 points, or 1.53% to 8,626; the Hang Seng TECH Index now
fell 116 points, or 1.89% to 6,062; with an overall turnover of HK$8.07b.
The SSE Composite Index now rose 10 points, or 0.31% to 3,547, with an overall turnover
of RMB32.88b.
The SZSE Component Index now rose 93 points, or 0.67% to 14,172, with an overall
turnover of RMB16.44b.
Basic Information
-------------------------------------------
Nominal 6.980 % Chg -0.99%
High 7.090 Low 6.980
Shares Tr 30,000 Turnover 211,590
10-D SMA 7.178 %H.V 32.084
20-D SMA 7.458 VWAP 7.053
50-D SMA 8.262 RSI14 31.964
-------------------------------------------
Status: Hitting a historical low, active buy/sell ratio is 4:96, with net selling
turnover of HK$183,230, falling a combined 4.38% over the past 6 consecutive
trading days
Table: Performance of stocks in the same sector or of relevance
Stock (Code) Price(HK$) Change(%)
-------------------------------------------------
SIMCERE PHARMA (02096) 6.98 -0.99
SIHUAN PHARM (00460) 1.59 +2.58
TRAD CHI MED (00570) 3.59 -1.64
CSPC PHARMA (01093) 9.20 -2.44
SINO BIOPHARM (01177) 6.29 -0.32
LIVZON PHARMA (01513) 28.00 -2.10
SSY GROUP (02005) 4.02 +2.03
FOSUN PHARMA (02196) 40.45 Unchanged
WUXI APPTEC (02359) 178.50 +0.45
CHINARES PHARMA (03320) 3.75 -0.27
-------------------------------------------------
(ed)